Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 5/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.41 |
| ▸ | LMNA | P02545 | 4/20 | 0.41 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.40 |
| ▸ | SRC | P12931 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8938993 | 0.94 | MEN1 (0.42) | HPGDTDP1L3MBTL1MEN1KMT2A | |
| SCHEMBL8939023 | 0.94 | HPGD (0.44) | HPGDTDP1L3MBTL1MEN1KMT2A | |
| SCHEMBL8938991 | 0.92 | PKM (0.43) | HPGDTDP1LMNAALDH1A1NPSR1 | |
| SCHEMBL8939044 | 0.91 | PKM (0.42) | HPGDTDP1L3MBTL1MEN1KMT2A | |
| SCHEMBL8938989 | 0.88 | KMT2A (0.37) | HPGDMEN1KMT2ALMNASRC | |
| SCHEMBL8939028 | 0.88 | L3MBTL1 (0.44) | HPGDTDP1L3MBTL1MEN1KMT2A | |
| SCHEMBL8938998 | 0.86 | SMN1; SMN2 (0.36) | HPGDL3MBTL1MEN1KMT2ALMNA | |
| SCHEMBL8939048 | 0.85 | MEN1 (0.40) | HPGDTDP1MEN1KMT2ALMNA | |
| SCHEMBL710803 | 0.85 | POLB (0.38) | HPGDTDP1MEN1KMT2ALMNA | |
| SCHEMBL8939019 | 0.85 | HPGD (0.38) | HPGDTDP1L3MBTL1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117980360-A | Composition for encapsulating organic light emitting device and organic light emitting device display apparatus including organic layer prepared therefrom | 三星SDI株式会社 | 2024-05-03 | — | — | CN | claimed |
| WO-2023048351-A1 | COMPOSITION FOR ENCAPSULATING ORGANIC LIGHT-EMITTING DEVICE AND ORGANIC LIGHT-EMITTING DEVICE DISPLAY APPARATUS COMPRISING ORGANIC LAYER PREPARED THEREFROM | 삼성에스디아이 주식회사 | 2023-03-30 | — | — | WO | claimed |
| EP-2290459-B1 | Carbon nanotube containing intermediate transfer members | XEROX CORP (US) | 2016-12-21 | — | — | EP | claimed |
| US-8993650-B2 | Mixable and color tone freely reproducible dental coloring material composition, and set and method thereof | KABUSHIKI KAISHA SHOFU (JP) | 2015-03-31 | — | — | US | claimed |
| US-20120049124-A1 | POLYESTER POLYOL ACRYLATE CONTAINING INTERMEDIATE TRANSFER MEMBERS | XEROX CORPORATION (US) | 2012-03-01 | — | — | US | claimed |
| US-20110244203-A1 | SILANE ACRYLATE CONTAINING INTERMEDIATE TRANSFER MEMBERS | XEROX CORPORATION (US) | 2011-10-06 | — | — | US | claimed |
| US-7976935-B2 | Carbon nanotube containing intermediate transfer members | XEROX CORPORATION (US) | 2011-07-12 | — | — | US | claimed |
| EP-0600373-A1 | Alkyl-arylesters of arylphosphonous acid process for their preparation and their use | HOECHST AKTIENGESELLSCHAFT (DE) | 1994-06-08 | — | — | EP | claimed |
| EP-3458520-B1 | CURABLE, DUAL CURE, ONE PART SILICONE COMPOSITION | MOMENTIVE PERFORMANCE MAT INC (US) | 2025-11-05 | — | — | EP | disclosed |
| CN-114269865-B | Radiation curable composition for plating applications | 爱克发-格法特公司 | 2024-07-02 | — | — | CN | disclosed |
| CN-118265741-A | Composition for encapsulating organic light emitting diode and organic light emitting diode display including organic layer manufactured therefrom | 三星SDI株式会社 | 2024-06-28 | — | — | CN | disclosed |
| CN-117980360-A | Composition for encapsulating organic light emitting device and organic light emitting device display apparatus including organic layer prepared therefrom | 三星SDI株式会社 | 2024-05-03 | — | — | CN | disclosed |
| CN-117940470-A | Composition for encapsulating organic light emitting element and organic light emitting element display device including organic layer produced therefrom | 三星SDI株式会社 | 2024-04-26 | — | — | CN | disclosed |
| CN-117836344-A | Dual cure resin composition comprising uretdione containing compounds and use thereof in 3D printing | 巴斯夫欧洲公司 | 2024-04-05 | — | — | CN | disclosed |
| US-20090142672-A1 | OPTICAL RECORDING COMPOSITION AND HOLOGRAPHIC RECORDING MEDIUM | FUJIFILM CORPORATION (JP) | 2009-06-04 | — | — | US | disclosed |
| EP-0948955-B1 | POLYMERIZABLE DENTAL COMPOSITION | KURARAY CO (JP) | 2003-09-03 | — | — | EP | disclosed |
| US-6191191-B1 | USED AS BONDING AGENT, COMPOSITE RESIN, ADHESIVE AGENT, PRIMER AND OPAQUE PRIMER FOR DENTAL USE; LIGHT RESISTANCE; ADHESION TO TOOTH SURFACE AND METALS; COLORFASTNESS | KURARAY CO., LTD. (JP) | 2001-02-20 | — | — | US | disclosed |
| EP-0948955-A1 | POLYMERIZABLE DENTAL COMPOSITION | KURARAY CO., LTD. (JP) | 1999-10-13 | — | — | EP | disclosed |
| US-5498741-A | Alkyl aryl arylphosphonites, process for the preparation thereof and use thereof | HOECHST AKTIENGESELLSCHAFT (DE) | 1996-03-12 | — | — | US | disclosed |
| EP-0600373-A1 | Alkyl-arylesters of arylphosphonous acid process for their preparation and their use | HOECHST AKTIENGESELLSCHAFT (DE) | 1994-06-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090142672-A1 | OPTICAL RECORDING COMPOSITION AND HOLOGRAPHIC RECORDING MEDIUM | CRY1, CRY2, CACNA1B | HPGD 1179/4885TDP1 3931/4885L3MBTL1 3490/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.